News

Zymenex sells clinical candidate Metazym to Shire for 135 MUSD
Zymenex gets US Orphan Approval
Zymenex gets FDA approval of IND
US Natural History Study of MLD
Zymenex has received a gracious grant from the ATHENA HOPE FOUNDATION..
Zymenex has received a gracious grant from The British Trust for The Myelin Project
Novel Natural History Study to answer question in Rare Disease
Phase II trial for Zymenex lethal disease treatment candidate
Zymenex in Phase I/II clinical trial in seriously ill children with MLD
Zymenex has recieved a gracious grant from the MLD Foundation (USA)
Page 1 of 3
Zymenex A/S Roskildevej 12 C
3400 Hillerød, DK
Tel  +45 48250054
Fax  +45 48251054
Affiliate Sweden Dalénum 13
181 70 Lidingö, S
Tel  +46 8 7670203
Fax  +46 8 7670233

© 2004 Zymenex A/S